CRBP
NASDAQ · Biotechnology
Corbus Pharmaceuticals Holdi
$9.56
+0.41 (+4.48%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+27.1% upside
Low Target
$8.71
Average Target
$12.15
High Target
$17.60
Current Price
$9.56
Current
$9.56
$9.56
Target
$12.15
$12.15
$8.71
$12.15 avg
$17.60
Scenario Analysis
Bear Case
$8.71
-8.9%
Low target
Base Case
$12.15
+27.1%
Avg target
Bull Case
$17.60
+84.1%
High target
Risk/Reward
9.5x
Highly favorable
Price in Context
52-Week High
$20.56
-53.5% from high
52-Week Low
$6.72
+42.3% from low
Target vs 52W High
$12.15
-40.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +20.5% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.2% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +178.4% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.1% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -88.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.2% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -23.9% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.0% |